Side-by-side comparison of AI visibility scores, market position, and capabilities
Second-largest US homebuilder; 80,000 homes FY2024; $35.4B revenue; Millrose Properties land REIT spin-off announced 2024 to create capital-light homebuilder model; "Everything's Included" strategy.
Lennar Corporation is the second-largest homebuilder in the United States by revenue, founded in 1954 by Leonard Miller and Arnold Rosen in Miami, Florida, where it remains headquartered, trading on NYSE (LEN). The company delivered approximately 80,000 homes in fiscal year 2024 (ending November 30) and generated approximately $35.4 billion in revenues under Executive Chairman Stuart Miller, with Jon Jaffe and Diane Bessette serving as co-CEOs. Lennar builds homes across entry-level, move-up, and active adult buyer segments in 26 states and over 100 metropolitan markets, with significant concentration in Florida, Texas, California, Georgia, and North Carolina—America's fastest-growing metropolitan areas where household formation and domestic migration trends support sustained demand. Lennar's "Everything's Included" merchandising strategy bundles premium features into base home prices, simplifying the purchase experience and improving per-home revenue per square foot versus competitors offering extensive à la carte options.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.